(MedPage Today) — SGLT2 inhibitors and GLP-1 receptor agonists were associated with fewer exacerbations of chronic obstructive pulmonary disease (COPD), according to propensity score-matched cohort studies that emulated randomized clinical trials…
Source link : https://www.medpagetoday.com/pulmonology/smokingcopd/114153
Author :
Publish date : 2025-02-10 17:18:20
Copyright for syndicated content belongs to the linked Source.
